Complete Filing Data
Foresight Autonomous Holdings Ltd. reported Net Income Loss of -$12.10 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Foresight Autonomous Holdings Ltd. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $398.0K | $436.0K | $497.0K | $550.0K | $120.0K | ||||||
| Net Income Loss | -$12.1M | -$11.1M | -$18.4M | -$21.7M | -$15.0M | -$15.4M | -$15.4M | -$14.7M | -$15.9M | -$1.9M | -$157.0K |
| Research And Development Expense | $8.6M | $9.1M | $11.6M | $11.5M | $10.2M | $8.6M | $10.2M | $8.6M | $4.1M | $904.0K | $131.0K |
| Operating Income Loss | -$12.2M | -$12.7M | -$16.3M | -$17.5M | -$15.9M | -$12.8M | -$15.0M | -$13.3M | -$8.9M | -$3.8M | -$157.0K |
| Selling And Marketing Expense | $1.2M | $1.1M | $1.9M | $2.2M | $1.8M | $1.3M | $1.4M | $987.0K | $1.0M | $224.0K | |
| Nonoperating Income Expense | $78.0K | $1.5M | -$2.1M | -$4.2M | $909.0K | $179.0K | $429.0K | $1.6M | -$7.2M | $2.0M | |
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | $1.7M | $83.0K | $3.5M | $4.6M | $2.9M | $3.9M | $3.6M | $3.2M | $11.2M | -$397.0K | |
| General And Administrative Expense | $2.6M | $2.7M | $3.1M | $4.0M | $4.0M | $3.0M | $3.5M | $3.7M | $3.8M | $2.6M | $26.0K |
| Income Loss From Equity Method Investments | -$2.7M | -$839.0K | -$2.9M | $156.0K | -$108.0K | ||||||
| Gross Profit | $258.0K | $264.0K | $354.0K | $298.0K | $53.0K | ||||||
| Cost Of Revenue | $140.0K | $172.0K | $143.0K | $252.0K | $67.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2018 |
|---|---|
| Revenue * | |
| Net Income Loss | |
| Research And Development Expense | |
| Operating Income Loss | |
| Selling And Marketing Expense | |
| Nonoperating Income Expense | |
| Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities | |
| General And Administrative Expense | |
| Income Loss From Equity Method Investments | $453.0K |
| Gross Profit | |
| Cost Of Revenue |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity * | $6.2M | $6.1M | $15.4M | $28.3M | $48.4M | $47.0M | $16.3M | $23.6M | $24.8M | $4.7M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.3M | $7.2M | $15.7M | $19.3M | $28.2M | $38.8M | $4.8M | $3.2M | ||
| Cash And Cash Equivalents At Carrying Value | $6.2M | $7.1M | $15.6M | $19.2M | $28.1M | $38.8M | $4.8M | $3.2M | $9.6M | $3.4M |
| Exchange Rate Changes On Cash And Cash Equivalents | -$109.0K | $185.0K | -$112.0K | $839.0K | $37.0K | -$75.0K | $182.0K | $237.0K | $282.0K | $70.0K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$893.0K | -$8.6M | -$3.5M | -$8.9M | -$10.6M | $33.9M | $1.7M | |||
| Retained Earnings Accumulated Deficit | -$142.9M | -$131.0M | -$119.9M | -$101.5M | -$79.8M | -$64.8M | -$49.4M | -$34.0M | -$19.3M | -$3.4M |
| Property Plant And Equipment Net | $187.0K | $323.0K | $461.0K | $598.0K | $503.0K | $427.0K | $631.0K | $787.0K | $289.0K | $67.0K |
| Other Receivables Net Current | $398.0K | $480.0K | $531.0K | $842.0K | $660.0K | $401.0K | $613.0K | $471.0K | $482.0K | $104.0K |
| Liabilities Current | $2.1M | $1.7M | $2.2M | $2.6M | $2.7M | $2.0M | $2.0M | $1.3M | $1.1M | $457.0K |
| Liabilities And Stockholders Equity | $8.4M | $9.7M | $19.3M | $32.9M | $53.5M | $49.9M | $19.3M | $24.9M | $28.0M | $5.3M |
| Liabilities | $3.2M | $3.0M | $3.3M | $4.1M | $4.8M | $2.9M | $3.0M | $1.3M | $3.2M | $588.0K |
| Assets Noncurrent | $1.5M | $1.9M | $2.3M | $5.6M | $7.1M | $5.5M | $8.6M | $8.4M | $3.4M | $1.4M |
| Assets Current | $6.8M | $7.8M | $17.0M | $27.3M | $46.4M | $44.4M | $10.7M | $16.5M | $24.7M | $3.9M |
| Assets | $8.4M | $9.7M | $19.3M | $32.9M | $53.5M | $49.9M | $19.3M | $24.9M | $28.0M | $5.3M |
| Accounts Payable Trade Current | $249.0K | $297.0K | $136.0K | $315.0K | $253.0K | $391.0K | $498.0K | $344.0K | $330.0K | $104.0K |
| Revaluation Of Marketable Securities | $45.0K | -$1.4M | $2.3M | $2.2M | $30.0K | -$87.0K | ||||
| Operating Lease Right Of Use Asset | $1.3M | $1.6M | $1.8M | $2.2M | $2.6M | $1.1M | $1.3M | |||
| Other Liabilities Current | $1.5M | $1.2M | $1.5M | $1.8M | $1.9M | $1.2M | $1.1M | $947.0K | $817.0K | $353.0K |
| Operating Lease Liability Noncurrent | $1.2M | $1.3M | $1.2M | $1.5M | $2.1M | $853.0K | $1.0M | |||
| Operating Lease Liability Current | $339.0K | $289.0K | $468.0K | $527.0K | $587.0K | $427.0K | $411.0K | |||
| Marketable Securities Current | $26.0K | $71.0K | $474.0K | $2.0K | $12.0K | $23.0K | $23.0K | $22.0K | ||
| Minority Interest | -$1.1M | $664.0K | $603.0K | $453.0K | $228.0K | $74.0K | ||||
| Short Term Investments | $17.5M | $5.2M | $5.2M | $12.5M | $12.2M | $390.0K | ||||
| Restricted Cash Current | $53.0K | $100.0K | $99.0K | $102.0K | $115.0K | |||||
| Gain Loss On Sale Of Equity Investments | -$839.0K | -$2.9M | $156.0K | -$108.0K | ||||||
| Cash And Cash Equivalents Period Increase Decrease | $33.9M | $1.7M | -$6.5M | $6.3M | $3.4M | |||||
| Investments | $6.7M | $7.6M | $1.4M | $1.2M | ||||||
| Gain Loss On Sale Of Other Investments | -$324.0K | $316.0K | $4.0M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Cash Provided By Used In Operating Activities | -$10.5M | -$11.1M | -$14.9M | -$17.1M | -$12.1M | -$11.5M | -$11.9M | -$11.5M | -$4.8M | -$2.3M | -$157.0K |
| Net Cash Provided By Used In Investing Activities | -$25.0K | $1.8M | $7.1M | $9.0M | -$12.6M | $85.0K | $7.2M | -$6.1M | -$12.1M | -$1.8M | |
| Increase Decrease In Other Accounts Payable | $385.0K | -$209.0K | -$244.0K | -$72.0K | $651.0K | -$68.0K | $213.0K | $130.0K | $464.0K | $232.0K | |
| Increase Decrease In Accounts Payable Trade | -$48.0K | $161.0K | -$179.0K | $62.0K | -$138.0K | -$296.0K | $154.0K | $14.0K | $226.0K | $104.0K | |
| Share Based Compensation | $947.0K | $788.0K | $1.4M | $1.8M | $2.5M | $1.2M | $1.6M | $2.0M | $2.5M | $405.0K | |
| Payments To Acquire Property Plant And Equipment | $25.0K | $62.0K | $124.0K | $313.0K | $235.0K | $50.0K | $103.0K | $733.0K | $271.0K | $73.0K | |
| Net Cash Provided By Used In Financing Activities | $9.5M | $903.0K | $4.2M | $14.2M | $45.3M | $6.5M | $11.4M | $23.4M | $7.5M | $157.0K | |
| Payments For Proceeds From Short Term Investments | -$7.2M | -$10.3M | $12.3M | -$67.0K | -$7.3M | $337.0K | $11.8M | $390.0K | |||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $109.0K | -$185.0K | $112.0K | -$839.0K | -$37.0K | $75.0K | -$182.0K | ||||
| Increase Decrease In Other Receivables | $378.0K | $2.0K | |||||||||
| Increase Decrease In Other Operating Liabilities | $192.0K | $156.0K | -$18.0K | -$289.0K | -$33.0K | $60.0K | $110.0K | ||||
| Stock Issued During Period Value Share Based Compensation | $947.0K | $788.0K | $1.4M | $1.8M | $2.5M | $1.2M | $1.6M | $2.0M | $2.5M | ||
| Proceeds From Issuance Of Warrants | $13.5M | $45.0M | $6.5M | $11.2M | $10.7M | $6.3M | |||||
| Increase Decrease In Other Current Assets | -$82.0K | -$51.0K | -$311.0K | $182.0K | $259.0K | -$212.0K | $142.0K | -$11.0K | $378.0K | -$427.0K | |
| Effect Of Exchange Rate On Cash And Cash Equivalents | $75.0K | -$182.0K | -$237.0K | -$282.0K | -$70.0K | ||||||
| Increase Decrease In Accounts And Other Receivables | $5.0K | -$195.0K | $308.0K | ||||||||
| Proceeds From Warrant Exercises | $595.0K | $125.0K | $12.0M | ||||||||
| Proceeds From Stock Options Exercised | $57.0K | $263.0K | $34.0K | $641.0K | |||||||
| Stock Issued During Period Value Share Based Compensation Gross | $2.0M | $2.5M | $405.0K | ||||||||
| Proceeds From Issuance Of Common Stock | $9.5M | $903.0K | $4.2M | $13.5M | $45.0M |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | -$0.14 | -$0.42 | -$0.07 | -$0.05 | -$0.07 | -$0.10 | -$0.12 | -$0.17 | -$0.03 | $0.00 |
| Common Stock Shares Outstanding | 140.6M | 72.7M | 459.8M | 323.0M | 322.7M | 312.8M | 154.6M | 131.9M | 109.5M | 73.1M | |
| Common Stock Shares Issued | 140.6M | 72.7M | 459.8M | 323.0M | 322.7M | 312.8M | 154.6M | 131.9M | 109.5M | 73.1M | |
| Common Stock Shares Authorized | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 1.00B | 200.0M | |
| Weighted Average Number Of Shares Outstanding Basic | 100.7M | 66.7M | 47.3M | 322.8M | 321.4M | 219.9M | 149.5M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 100.7M | 66.7M | 47.3M | 322.8M | 321.4M | ||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 219.9M | 149.5M | 120.6M | 94.4K | 67.3K | 35.9M | |||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||
| Earnings Per Share Basic | $-0.12 | $-0.14 | $-0.42 | $-0.07 | $-0.05 | $-0.07 | $-0.10 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Depreciation | $161.0K | $200.0K | $263.0K | $218.0K | $159.0K | $254.0K | $259.0K | $235.0K | $49.0K | $11.0K |
| Additional Paid In Capital | $149.2M | $137.1M | $135.3M | $129.8M | $128.2M | $111.7M | $65.7M | $57.5M | $44.1M | $8.0M |
| Stock Issued During Period Value New Issues | $4.0M | $903.0K | $4.2M | $13.5M | $44.7M | $6.5M | $1.7M | |||
| Stock Issued During Period Value Stock Options Exercised | $4.0K | $57.0K | $263.0K | $34.0K | $641.0K | |||||
| Fair Value Adjustment Of Warrants | $1.0K | -$2.1M | $12.2M | -$1.8M | ||||||
| Trading Securities Realized Gain Loss | $1.0K | $4.0K | $104.0K | |||||||
| Stock Issued During Period Value Other | $4.5M | $6.5M | $11.2M | $10.7M | $4.4M | |||||
| Stock Issued During Period Value Exercise Of Warrants | $595.0K | $125.0K | $22.2M |
Most recent annual filing with the SEC: March 25, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.